Recent Company News

• 08:33 AM ET Apr 30, 2026
  

  Teva Pharmaceutical releases sustainability report ($35.38, 0.00)

• 08:30 AM ET Apr 30, 2026
  

  Teva's 2025 Healthy Future Report Highlights Environmental and Access to Medicines Progress, Including Meeting All Sustainability-Linked Bond Targets

• 05:04 PM ET Apr 29, 2026
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 10:34 AM ET Apr 29, 2026
  

  Transcript Intelligence: Teva Pharmaceutical Q1 Earnings Q&A ($34.43, +2.81)

• 10:34 AM ET Apr 29, 2026
  

  Transcript Intelligence: Teva Pharmaceutical Q1 Earnings Themes ($34.48, +2.86)

• 10:34 AM ET Apr 29, 2026
  

  Transcript Intelligence: Teva Pharmaceutical Q1 Earnings Guidance ($34.46, +2.84)

• 08:59 AM ET Apr 29, 2026
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 08:21 AM ET Apr 29, 2026
  

  StreetAccount Summary - US Pre-market trading

• 07:34 AM ET Apr 29, 2026
  

  MedinCell notes partner Teva Pharmaceutical's UZEDY Q1 sales at $63M, +62% y/y (€24.54, +1.68)

• 07:20 AM ET Apr 29, 2026
  

  StreetAccount Metrics Recap - Teva Pharmaceutical Q1 Earnings ($31.62, 0.00)